Biodesix, Inc.
BDSX
$0.4338
$0.00020.05%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.71% | 14.11% | 17.67% | 30.82% | 32.66% |
| Total Depreciation and Amortization | 8.20% | 7.64% | 4.83% | -3.74% | -14.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -44.15% | -34.42% | -18.35% | -36.36% | -27.45% |
| Change in Net Operating Assets | 93.21% | -1,118.90% | -291.69% | -256.27% | -268.77% |
| Cash from Operations | 40.13% | -37.53% | -112.72% | -152.21% | -72.26% |
| Capital Expenditure | 89.12% | 80.16% | 85.91% | 75.42% | 34.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.21% | -53.95% | -46.85% | 0.55% | 6.67% |
| Cash from Investing | 87.43% | 78.86% | 85.08% | 74.80% | 34.31% |
| Total Debt Issued | 0.00% | -- | -- | -66.67% | -66.67% |
| Total Debt Repaid | 24.00% | 10.00% | -4.08% | 99.78% | 99.80% |
| Issuance of Common Stock | -99.20% | 89.74% | 94.99% | 19.64% | 90.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 90.46% | 38.49% | 56.89% | 65.96% | 40.24% |
| Cash from Financing | -88.54% | 58.80% | 78.69% | 50.17% | 146.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -186.62% | 144.34% | 99.77% | 147.88% | 321.99% |